We are live on
!
Find out more
MC
Mathes Company Portfolio holdings
AUM
$274M
1-Year Est. Return
33.72%
This Fund
S&P 500
This Quarter
Est. Return
+4.16%
1 Year Est. Return
+33.72%
3 Year Est. Return
+105.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$274M
AUM Growth
-$9.44M
(-3.3%)
Cap. Flow
-$18.1M
Cap. Flow
% of AUM
-6.6%
Top 10 Holdings %
Top 10 Hldgs %
36.68%
Holding
129
New
2
Increased
8
Reduced
53
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$3.61M |
| 2 |
Eli Lilly
LLY
|
+$464K |
| 3 |
Trade Desk
TTD
|
+$247K |
| 4 |
BlackRock Capital Allocation Term Trust
BCAT
|
+$214K |
| 5 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$109K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$2.54M |
| 2 |
SLY
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
|
+$2.12M |
| 3 |
iShares US Medical Devices ETF
IHI
|
+$2.03M |
| 4 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$1.35M |
| 5 |
iShares Expanded Tech Sector ETF
IGM
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 15.07% |
| 3 | Financials | 7.41% |
| 4 | Communication Services | 5.78% |
| 5 | Consumer Staples | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
GE HealthCare
GEHC
$30.7B
| $3.77M | 1.37% |
48,171
-1,080
| -2% | -$91.8K |
|
27
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.7B
| $3.72M | 1.36% |
33,200
| – | – |
|
28
PepsiCo
PEP
$191B
| $3.61M | 1.32% |
23,731
-100
| -0.4% | -$16.4K |
|
29
FedEx
FDX
$73.1B
| $3.27M | 1.19% |
11,610
-910
| -7% | -$254K |
|
30
Danaher
DHR
$138B
| $3.19M | 1.16% |
13,896
-50
| -0.4% | -$12.3K |
|
31
EOG Resources
EOG
$78.5B
| $2.97M | 1.09% |
24,259
-800
| -3% | -$102K |
|
32
Vanguard Morningstar Large-Cap ETF
VV
$52.4B
| $2.96M | 1.08% |
10,961
-2,500
| -19% | -$677K |
|
33
State Street SPDR S&P 500 ETF Trust
SPY
$789B
| $2.85M | 1.04% |
4,870
-60
| -1% | -$35.4K |
|
34
Emerson Electric
EMR
$84.2B
| $2.83M | 1.03% |
22,795
-1,150
| -5% | -$139K |
|
35
Air Products & Chemicals
APD
$65.5B
| $2.69M | 0.98% |
9,279
-731
| -7% | -$230K |
|
36
Costco
COST
$423B
| $2.27M | 0.83% |
2,474
-30
| -1% | -$27.8K |
|
37
Coca-Cola
KO
$377B
| $2.22M | 0.81% |
35,645
-50
| -0.1% | -$3.26K |
|
38
Valero Energy
VLO
$92B
| $2.21M | 0.81% |
18,065
-1,675
| -8% | -$224K |
|
39
McCormick & Company Non-Voting
MKC
$13.8B
| $2.2M | 0.8% |
28,877
+900
| +3% | +$70.7K |
|
40
iShares Russell 2000 ETF
IWM
$79.9B
| $2.19M | 0.8% |
9,930
-480
| -5% | -$109K |
|
41
Invesco QQQ Trust
QQQ
$453B
| $2.15M | 0.79% |
4,210
| – | – |
|
42
AT&T
T
$159B
| $2.13M | 0.78% |
93,594
| – | – |
|
43
State Street
STT
$50.6B
| $2.1M | 0.77% |
21,450
-450
| -2% | -$42.6K |
|
|
44
BlackRock Capital Allocation Term Trust
BCAT
$1.65B
| $1.66M | 0.61% |
109,800
+13,300
| +14% | +$214K |
|
45
Bank of America
BAC
$435B
| $1.62M | 0.59% |
36,900
| – | – |
|
46
Netflix
NFLX
$299B
| $1.48M | 0.54% |
16,640
-550
| -3% | -$45.3K |
|
47
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.3B
| $1.48M | 0.54% |
5,820
| – | – |
|
48
Alphabet (Google) Class C
GOOG
$4.34T
| $1.3M | 0.48% |
6,851
-200
| -3% | -$35.3K |
|
49
iShares Dow Jones US ETF
IYY
$2.95B
| $1.29M | 0.47% |
9,000
| – | – |
|
50
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $1.26M | 0.46% |
40,150
-15,700
| -28% | -$513K |
|
Similar funds
SN
OL
JWM
MP
3C
SCM
ACM
LAM
Mathes Company's Q4 2024 Portfolio in Review
As of Q4 2024, Mathes Company held 129 positions worth $274M, down 3.3% from $283M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mathes Company withdrew a net $18.1M in Q4 2024, closing 5 positions and reducing 53 holdings. Its most notable exit was Novo Nordisk, an estimated $499K position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
Against the trend, Mathes Company opened a new position in Eli Lilly worth $432K.
- Mathes Company's largest Q4 2024 buy was Eli Lilly: 560 shares worth $432K.
- Mathes Company added most to Procter & Gamble in Q4 2024, an estimated $3.61M increase.
- Mathes Company's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $2.54M.
- Mathes Company fully exited Novo Nordisk in Q4 2024, selling an estimated $499K.
- Mathes Company's ten largest holdings make up 37% of its $274M portfolio in Q4 2024.
- Mathes Company opened 2 new positions and closed 5 in Q4 2024.
- Mathes Company's portfolio value fell 3.3% quarter-over-quarter to $274M.
Based on Mathes Company's 13F filing for Q4 2024, filed 31 Jan 2025.